The Impact of Fecal Microbiota Transplantation on the Intestinal Microecology of Patients with Colorectal Cancer
Abstract
and thereby improve clinical symptoms and prognosis of patients with colorectal cancer. This study found that FMT can effectively alter the
intestinal microbiota structure of patients with colorectal cancer, increase microbial diversity, reduce intestinal inflammation, and potentially
enhance the patients immune function. However, FMT still faces challenges in clinical application, such as donor selection, ethical issues,
and the stability of transplantation effects. Future research needs to further explore optimization strategies for FMT to fully realize its potential
in the treatment of colorectal cancer.
Keywords
Full Text:
PDFReferences
[1] Han Caiyun, Liu Yuedong, Jia Hanze. Research Progress on the Treatment of Functional Constipation by Regulating Intestinal Microecology [J]. Journal of Practical Traditional Chinese Internal Medicine, 2024, 38(04): 74-76.
[2] Zhang Lu, Yuan Hao, Guo Qinghong. Research Status of Intestinal Microecology in Complications of Liver Cirrhosis [J]. Modern Digestion & Intervention, 2023, 28(11): 1448-1451.
[3] Chen Liyu, Geng Yan. Research Progress on the Impact of Intestinal Bacteriophages on Diseases in Fecal Microbiota Transplantation
Technology [J]. Microbiology and Infection, 2023, 18(05): 297-306.
[4] Guo Zhi, Wang Jun, Wang Qiang. Guidelines for Integrative Diagnosis and Treatment of Intestinal Microecology Technology (Abbreviated Version) by Chinese Anti-Cancer Association [J]. Chinese Journal of Clinical Oncology, 2023, 50(18): 919-927.
[5] Xu Sheng, Weng Danping, Zeng Yue, et al. Research Progress of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy [J]. Journal of Hepatology, 2023, 28(07): 872-875.
Refbacks
- There are currently no refbacks.
